Arrowhead Pharmaceuticals · 20 hours ago
Summer Intern, Antibody Discovery
Arrowhead Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing innovative drugs for genetic diseases. The Antibody Discovery Summer Intern will support research in antibody development and screening, gaining hands-on experience in molecular biology and biochemistry while collaborating with scientists.
BiotechnologyHealth CareNanotechnologyPharmaceutical
Responsibilities
Culture mammalian cells to produce and test proteins
Clone DNA constructs to support protein and antibody expression
Express and purify novel antibody constructs
Screen novel biologics and oligonucleotides for in vitro activity
Investigate cell binding, internalization, and trafficking of antibodies and receptors
Maintain accurate and well-organized experimental records
Collaborate effectively within a cross-functional research team
Follow established laboratory procedures, safety guidelines, and quality standards
Present project updates in weekly group meetings
Prepare final deliverables, including a scientific poster and a ~20-minute presentation summarizing project objectives, results, and learning
Qualification
Required
Currently enrolled student at an accredited university or college with 2–3 years of college-level coursework in Biochemistry, Biology, or a related scientific discipline
Excellent verbal and written communication skills, including comfort presenting in group settings
Strong problem-solving and organizational skills
Proficiency in Microsoft Office applications
Ability to lift up to 40 lbs
Willingness and ability to spend 75% of the workday in laboratory environments and 25% at a desk
Preferred
Completion of coursework in Organic Chemistry, Biochemistry, Molecular Biology, and Immunology
Prior laboratory experience, including molecular biology or cell-based assays
Strong interest in antibody engineering, biologics, or drug discovery research
Benefits
Competitive salaries
Excellent benefit package
Company
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals is a biotechnology company that focuses on the development of medicine to treat diseases with a genetic origin.
Funding
Current Stage
Public CompanyTotal Funding
$2.45BKey Investors
Sarepta TherapeuticsSixth StreetSilence Therapeutics
2026-01-07Post Ipo Equity· $200M
2026-01-07Post Ipo Debt· $625M
2024-11-26Post Ipo Equity· $325M
Leadership Team
Recent News
2026-01-08
2026-01-07
Company data provided by crunchbase